Evaluation of the psychological state of patients suspected of Lynch syndrome after the germline genetic testing result. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
Vigil Neuroscience reported positive Phase 1 trial results for VG-3927 and plans a Phase 2 trial in Q3 2025. Vigil Neuroscience, Inc. announced promising outcomes from a Phase 1 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback